Biogen (BIIB) on Watch Amid Renewed Chatter
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Biogen (NASDAQ: BIIB) was on watch amid renewed takeover chatter. Chatter suggests Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ) may also be interested in the company. The source of the rumor was said to be DealReporter.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Dr Pepper Snapple Group (DPS) Said in Talks to Buy Bai Brands - Reuters
- UPDATE: All Apple (AAPL) iPhone 8 models likely to have glass backs - Nikkei
- Concho Resources (CXO), PE Investors Seek Buyer for Pipeline System Alpha Crude Connector - DJ